Addressing Excipient Variability in Formulation Design and Drug Development
暂无分享,去创建一个
[1] L. Augsburger,et al. The Influence of Product Brand-to-Brand Variability on Superdisintegrant Performance A Case Study with Croscarmellose Sodium , 2006, Pharmaceutical development and technology.
[2] Divyakant Desai,et al. Impact of Excipient Interactions on Solid Dosage Form Stability , 2012, Pharmaceutical Research.
[3] J. L. Gómez-Amoza,et al. Intersupplier and interlot variability in hydroxypropyl celluloses: implications for theophylline release from matrix tablets , 1998 .
[4] P. York,et al. Characterisation of the surface properties of α-lactose monohydrate with inverse gas chromatography, used to detect batch variation , 1996 .
[5] E. Doelker,et al. Comparative Tableting Properties of Sixteen Microcrystalline Celluloses , 1987 .
[6] A. Narang,et al. Chapter 6 – Excipient Compatibility , 2009 .
[7] J. Kushner,et al. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. , 2014, Journal of pharmaceutical sciences.
[8] J. Sjögren,et al. Evaluation of some lubricants by the comparison of friction coefficients and tablet properties. , 1981, Acta pharmaceutica Suecica.
[9] P. York,et al. Particle size effects on the dehydration of dicalcium phosphate dihydrate powders , 1994 .
[10] J. Kushner,et al. Examining the impact of excipient material property variation on drug product quality attributes: a quality-by-design study for a roller compacted, immediate release tablet. , 2011, Journal of pharmaceutical sciences.
[11] A. Narang,et al. Impact of Excipient Interactions on Drug Bioavailability from Solid Dosage Forms , 2012, Pharmaceutical Research.
[12] Joseph Kushner. Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development , 2013, Pharmaceutical development and technology.
[13] M. Manning,et al. Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. , 2005, Journal of pharmaceutical sciences.
[14] R. Johnson,et al. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. , 1998, Journal of pharmaceutical sciences.
[15] Jérôme Barra,et al. Influence of the Physicochemical Variability of Magnesium Stearate on Its Lubricant Properties: Possible Solutions , 1996 .
[16] J. L. Gómez-Amoza,et al. The effect of country of origin on the properties of dicalcium phosphate dihydrate powder , 1994 .
[17] Lawrence X. Yu. Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control , 2008, Pharmaceutical Research.
[18] Robert A Reed,et al. The role of excipients and package components in the photostability of liquid formulations. , 2003, PDA journal of pharmaceutical science and technology.
[19] S. Alsaidan,et al. Improved dissolution rate of indomethacin by adsorbents. , 1998, Drug development and industrial pharmacy.
[20] R. Williams,et al. Compaction properties of microcrystalline cellulose using tableting indices , 1997 .
[21] Compendial standards and excipient performance in the QbD era: USP excipient performance chapter 〈1059〉 , 2011 .
[22] D. Bindra,et al. Reversible and pH‐dependent weak drug‐excipient binding does not affect oral bioavailability of high dose drugs , 2012, The Journal of pharmacy and pharmacology.
[23] S. Moghimi,et al. Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels. , 2004, Biochimica et biophysica acta.
[24] S. Varia,et al. Effects of variations in physicochemical properties of glyceryl monostearate on the stability of an oil-in- , 1989 .
[25] J. L. Gómez-Amoza,et al. Interlot variability of carbomer 934 , 1993 .
[26] Vivek S. Dave,et al. Excipient variability and its impact on dosage form functionality. , 2015, Journal of pharmaceutical sciences.
[27] Torbjörn Lundstedt,et al. Robustness Testing of a Tablet Formulation Using Multivariate Design , 2006, Drug development and industrial pharmacy.
[28] Ganeshkumar A. Subramanian,et al. Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation. , 2012, International journal of pharmaceutics.
[29] R. Pinal,et al. Elucidating Raw Material Variability—Importance of Surface Properties and Functionality in Pharmaceutical Powders , 2009, AAPS PharmSciTech.
[30] L. Augsburger,et al. Increasing the Dissolution Rate of a Low-Solubility Drug Through a Crystalline-Amorphous Transition: A Case Study with Indomethicin , 2008, Drug development and industrial pharmacy.
[31] Physicochemical Interactions in Solid Dosage Forms , 2012, Pharmaceutical Research.
[32] A. Narang,et al. Effect of antioxidants and silicates on peroxides in povidone. , 2012, Journal of pharmaceutical sciences.
[33] C. Rhodes,et al. Effect of molecular structure variation on the disintegrant action of sodium starch glycolate. , 1985, Journal of pharmaceutical sciences.
[34] Ajit S. Narang,et al. Reactive Impurities in Excipients: Profiling, Identification and Mitigation of Drug–Excipient Incompatibility , 2011, AAPS PharmSciTech.
[35] A. Narang,et al. Formation of reactive impurities in aqueous and neat polyethylene glycol 400 and effects of antioxidants and oxidation inducers. , 2012, Journal of pharmaceutical sciences.
[36] Huiquan Wu,et al. Quality-by-design (QbD): an integrated multivariate approach for the component quantification in powder blends. , 2009, International journal of pharmaceutics.
[37] Hui Xu,et al. Evaluation of hydroperoxides in common pharmaceutical excipients. , 2007, Journal of pharmaceutical sciences.